{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:09:17Z","timestamp":1794812957700,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"42","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS087169"],"award-info":[{"award-number":["R01NS087169"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA228137-01A1"],"award-info":[{"award-number":["1R01CA228137-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA079448"],"award-info":[{"award-number":["T32CA079448"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA012197"],"award-info":[{"award-number":["P30CA012197"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1T32CA247819-01"],"award-info":[{"award-number":["1T32CA247819-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-17-1-0044"],"award-info":[{"award-number":["W81XWH-17-1-0044"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-19-1-0072"],"award-info":[{"award-number":["W81XWH-19-1-0072"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-19-1-0753"],"award-info":[{"award-number":["W81XWH-19-1-0753"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-20-1-0044"],"award-info":[{"award-number":["W81XWH-20-1-0044"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0044"],"award-info":[{"award-number":["W81XWH-20-1-0044"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,10,15]]},"DOI":"10.1038\/s41388-020-01454-1","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T17:03:12Z","timestamp":1600102992000},"page":"6589-6605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Combined inhibition of JAK2-STAT3 and SMO-GLI1\/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1455-3090","authenticated-orcid":false,"given":"Daniel","family":"Doheny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherona","family":"Sirkisoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah Reeve","family":"Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina T.","family":"Regua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlyn","family":"Anguelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara G.","family":"Manore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Abu","family":"Jalboush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin J.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Strowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-7914","authenticated-orcid":false,"given":"Hui-Wen","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"1454_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA: A Cancer J Clin"},{"key":"1454_CR2","unstructured":"Howlader NNA, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, et al., editors. SEER cancer statistics review, 1975\u20132016, Bethesda, MD: National Cancer Institute; 2019. https:\/\/seer.cancer.gov\/csr\/1975_2016\/, based on November 2018 SEER data submission, posted to the SEER web site. Vol. 2020. p. 1975\u20132016."},{"key":"1454_CR3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature"},{"key":"1454_CR4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa052933","volume":"355","author":"C Fan","year":"2006","unstructured":"Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006;355:560\u20139.","journal-title":"N Engl J Med"},{"key":"1454_CR5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jjco\/hyu126","volume":"44","author":"S Kuba","year":"2014","unstructured":"Kuba S, Ishida M, Nakamura Y, Yamanouchi K, Minami S, Taguchi K, et al. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype. Jpn J Clin Oncol. 2014;44:1025\u201331.","journal-title":"Jpn J Clin Oncol"},{"key":"1454_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1990.8.1.103","volume":"8","author":"S Paik","year":"1990","unstructured":"Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol. 1990;8:103\u201312.","journal-title":"J Clin Oncol"},{"key":"1454_CR7","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","volume":"17","author":"MA Cobleigh","year":"1999","unstructured":"Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol. 1999;17:2639\u201348.","journal-title":"J Clin Oncol"},{"key":"1454_CR8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1634\/theoncologist.2008-0816","volume":"13","author":"Q Ryan","year":"2008","unstructured":"Ryan Q, Ibrahim A, Cohen MH, Johnson J, Ko C-w, Sridhara R, et al. FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2. Oncologist. 2008;13:1114\u20139.","journal-title":"Oncologist"},{"key":"1454_CR9","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1158\/1078-0432.CCR-18-3003","volume":"25","author":"LJ Howie","year":"2019","unstructured":"Howie LJ, Scher NS, Amiri-Kordestani L, Zhang L, King-Kallimanis BL, Choudhry Y, et al. FDA approval summary: pertuzumab for adjuvant treatment of HER2-positive early breast cancer. Clin Cancer Res. 2019;25:2949\u201355.","journal-title":"Clin Cancer Res"},{"key":"1454_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1078155214527144","volume":"21","author":"JM Baron","year":"2015","unstructured":"Baron JM, Boster BL, Barnett CM. Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. J Oncol Pharm Pract. 2015;21:132\u201342.","journal-title":"J Oncol Pharm Pract"},{"key":"1454_CR11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","volume":"8","author":"S Al-Mahmood","year":"2018","unstructured":"Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res. 2018;8:1483\u2013507.","journal-title":"Drug Deliv Transl Res"},{"key":"1454_CR12","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.3747\/co.25.3954","volume":"25","author":"JM Lebert","year":"2018","unstructured":"Lebert JM, Lester R, Powell E, Seal M, McCarthy J. Advances in the systemic treatment of triple-negative breast cancer. Curr Oncol. 2018;25:S142\u2013s150.","journal-title":"Curr Oncol"},{"key":"1454_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrclinonc.2010.122","volume":"7","author":"C Palmieri","year":"2010","unstructured":"Palmieri C, Krell J, James CR, Harper-Wynne C, Misra V, Cleator S, et al. Rechallenging with anthracyclines and taxanes in metastatic breast cancer. Nat Rev Clin Oncol. 2010;7:561\u201374.","journal-title":"Nat Rev Clin Oncol"},{"key":"1454_CR14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-13-0286","volume":"4","author":"JM Balko","year":"2014","unstructured":"Balko JM, Giltnane JM, Wang K, Schwarz LJ, Young CD, Cook RS, et al. Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets. Cancer Discov. 2014;4:232\u201345.","journal-title":"Cancer Discov"},{"key":"1454_CR15","doi-asserted-by":"crossref","first-page":"334ra353","DOI":"10.1126\/scitranslmed.aad3001","volume":"8","author":"JM Balko","year":"2016","unstructured":"Balko JM, Schwarz LJ, Luo N, Estrada MV, Giltnane JM, Davila-Gonzalez D, et al. Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence. Sci Transl Med. 2016;8:334ra353.","journal-title":"Sci Transl Med"},{"key":"1454_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fonc.2019.00048","volume":"9","author":"CY Loh","year":"2019","unstructured":"Loh CY, Arya A, Naema AF, Wong WF, Sethi G, Looi CY. Signal transducer and activator of transcription (STATs) proteins in cancer and inflammation: functions and therapeutic implication. Front Oncol. 2019;9:48.","journal-title":"Front Oncol"},{"key":"1454_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"1454_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2017.12.003","volume":"415","author":"Y Wang","year":"2018","unstructured":"Wang Y, Shen Y, Wang S, Shen Q, Zhou X. The role of STAT3 in leading the crosstalk between human cancers and the immune system. Cancer Lett. 2018;415:117\u201328.","journal-title":"Cancer Lett"},{"key":"1454_CR19","doi-asserted-by":"crossref","first-page":"17603","DOI":"10.1073\/pnas.1208807109","volume":"109","author":"C Guo","year":"2012","unstructured":"Guo C, Chang CC, Wortham M, Chen LH, Kernagis DN, Qin X, et al. Global identification of MLL2-targeted loci reveals MLL2\u2019s role in diverse signaling pathways. Proc Natl Acad Sci USA. 2012;109:17603\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1454_CR20","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1158\/1078-0432.CCR-07-4923","volume":"14","author":"HW Lo","year":"2008","unstructured":"Lo HW, Cao X, Zhu H, Ali-Osman F. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators. Clin Cancer Res. 2008;14:6042\u201354.","journal-title":"Clin Cancer Res"},{"key":"1454_CR21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/1541-7786.MCR-09-0391","volume":"8","author":"H-W Lo","year":"2010","unstructured":"Lo H-W, Cao X, Zhu H, Ali-Osman F. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res. 2010;8:232\u201345.","journal-title":"Mol Cancer Res"},{"key":"1454_CR22","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1158\/0008-5472.CAN-07-0575","volume":"67","author":"HW Lo","year":"2007","unstructured":"Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007;67:9066\u201376.","journal-title":"Cancer Res"},{"key":"1454_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2005.05.007","volume":"7","author":"HW Lo","year":"2005","unstructured":"Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y, et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS\/NO pathway. Cancer Cell. 2005;7:575\u201389.","journal-title":"Cancer Cell"},{"key":"1454_CR24","first-page":"1445","volume":"15","author":"T Kusaba","year":"2006","unstructured":"Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Inoue K, et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep. 2006;15:1445\u201351.","journal-title":"Oncol Rep"},{"key":"1454_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","volume":"38","author":"J-J Qin","year":"2019","unstructured":"Qin J-J, Yan L, Zhang J, Zhang W-D. STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review. J Exp Clin Cancer Res. 2019;38:195.","journal-title":"J Exp Clin Cancer Res"},{"key":"1454_CR26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/cells8040375","volume":"8","author":"NA Riobo-Del Galdo","year":"2019","unstructured":"Riobo-Del Galdo NA, Lara Montero \u00c1, Wertheimer EV. Role of Hedgehog signaling in breast cancer: pathogenesis and therapeutics. Cells. 2019;8:375.","journal-title":"Cells"},{"key":"1454_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cub.2006.11.033","volume":"17","author":"V Clement","year":"2007","unstructured":"Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 2007;17:165\u201372.","journal-title":"Curr Biol"},{"key":"1454_CR28","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-08-3938","volume":"69","author":"M Fiaschi","year":"2009","unstructured":"Fiaschi M, Rozell B, Bergstrom A, Toftgard R. Development of mammary tumors by conditional expression of GLI1. Cancer Res. 2009;69:4810\u20137.","journal-title":"Cancer Res"},{"key":"1454_CR29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/332371a0","volume":"332","author":"KW Kinzler","year":"1988","unstructured":"Kinzler KW, Ruppert JM, Bigner SH, Vogelstein B. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature. 1988;332:371\u20134.","journal-title":"Nature"},{"key":"1454_CR30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0896-6273(03)00561-0","volume":"39","author":"R Machold","year":"2003","unstructured":"Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, Corbin JG, et al. Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron. 2003;39:937\u201350.","journal-title":"Neuron"},{"key":"1454_CR31","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","volume":"66","author":"S Liu","year":"2006","unstructured":"Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66:6063\u201371.","journal-title":"Cancer Res"},{"key":"1454_CR32","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/0008-5472.CAN-09-0886","volume":"69","author":"HW Lo","year":"2009","unstructured":"Lo HW, Zhu H, Cao X, Aldrich A, Ali-Osman F. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Res. 2009;69:6790\u20138.","journal-title":"Cancer Res"},{"key":"1454_CR33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/onc.2011.219","volume":"31","author":"X Cao","year":"2012","unstructured":"Cao X, Geradts J, Dewhirst MW, Lo HW. Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene. 2012;31:104\u201315.","journal-title":"Oncogene"},{"key":"1454_CR34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1166\/ch.2013.1006","volume":"1","author":"W Han","year":"2013","unstructured":"Han W, Carpenter RL, Lo H-W. TGLI1 upregulates expression of VEGFR2 and VEGF-A, leading to a robust VEGF-VEGFR2 autocrine loop and cancer cell growth. Cancer Hallm. 2013;1:28\u201337.","journal-title":"Cancer Hallm"},{"key":"1454_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2013.09.014","volume":"343","author":"H Zhu","year":"2014","unstructured":"Zhu H, Carpenter RL, Han W, Lo HW. The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth. Cancer Lett. 2014;343:51\u201361.","journal-title":"Cancer Lett"},{"key":"1454_CR36","doi-asserted-by":"crossref","first-page":"22653","DOI":"10.18632\/oncotarget.4248","volume":"6","author":"RL Carpenter","year":"2015","unstructured":"Carpenter RL, Paw I, Zhu H, Sirkisoon S, Xing F, Watabe K, et al. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis. Oncotarget. 2015;6:22653\u201365.","journal-title":"Oncotarget"},{"key":"1454_CR37","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1158\/0008-5472.CAN-17-2933","volume":"78","author":"TK Rimkus","year":"2018","unstructured":"Rimkus TK, Carpenter RL, Sirkisoon S, Zhu D, Pasche BC, Chan MD, et al. Truncated glioma-associated oncogene homolog 1 (tGLI1) mediates mesenchymal glioblastoma via transcriptional activation of CD44. Cancer Res. 2018;78:2589\u20132600.","journal-title":"Cancer Res"},{"key":"1454_CR38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41388-019-0959-3","volume":"39","author":"SR Sirkisoon","year":"2020","unstructured":"Sirkisoon SR, Carpenter RL, Rimkus T, Doheny D, Zhu D, Aguayo NR, et al. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment. Oncogene. 2020;39:64\u201378.","journal-title":"Oncogene"},{"key":"1454_CR39","first-page":"871","volume":"29","author":"C Kameda","year":"2009","unstructured":"Kameda C, Tanaka H, Yamasaki A, Nakamura M, Koga K, Sato N, et al. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. Anticancer Res. 2009;29:871\u20139.","journal-title":"Anticancer Res"},{"key":"1454_CR40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/2229-5178.120685","volume":"4","author":"S Aditya","year":"2013","unstructured":"Aditya S, Rattan A. Vismodegib: a smoothened inhibitor for the treatment of advanced basal cell carcinoma. Indian Dermatol Online J. 2013;4:365\u20138.","journal-title":"Indian Dermatol Online J"},{"key":"1454_CR41","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/OTT.S130910","volume":"10","author":"S Jain","year":"2017","unstructured":"Jain S, Song R, Xie J. Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas. OncoTargets Ther. 2017;10:1645\u201353.","journal-title":"OncoTargets Ther"},{"key":"1454_CR42","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/s41388-018-0132-4","volume":"37","author":"SR Sirkisoon","year":"2018","unstructured":"Sirkisoon SR, Carpenter RL, Rimkus T, Anderson A, Harrison A, Lange AM, et al. Interaction between STAT3 and GLI1\/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene. 2018;37:2502\u201314.","journal-title":"Oncogene"},{"key":"1454_CR43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym Regul. 1984;22:27\u201355.","journal-title":"Adv Enzym Regul"},{"key":"1454_CR44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","volume":"6","author":"RL Carpenter","year":"2014","unstructured":"Carpenter RL, Lo HW. STAT3 target genes relevant to human cancers. Cancers. 2014;6:897\u2013925.","journal-title":"Cancers"},{"key":"1454_CR45","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","volume":"16","author":"AA Merchant","year":"2010","unstructured":"Merchant AA, Matsui W. Targeting Hedgehog\u2014a cancer stem cell pathway. Clin Cancer Res. 2010;16:3130\u201340.","journal-title":"Clin Cancer Res"},{"key":"1454_CR46","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1454_CR47","doi-asserted-by":"crossref","first-page":"44191","DOI":"10.18632\/oncotarget.6176","volume":"6","author":"T Wang","year":"2015","unstructured":"Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, et al. Cancer stem cell targeted therapy: progress amid controversies. Oncotarget. 2015;6:44191\u2013206.","journal-title":"Oncotarget"},{"key":"1454_CR48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12011-014-0110-9","volume":"163","author":"Z Ackerman","year":"2015","unstructured":"Ackerman Z, Pappo O, Link G, Glazer M, Grozovski M. Liver toxicity of thioacetamide is increased by hepatocellular iron overload. Biol Trace Elem Res. 2015;163:169\u201376.","journal-title":"Biol Trace Elem Res"},{"key":"1454_CR49","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bbamcr.2012.03.015","volume":"1823","author":"HJ Choi","year":"2012","unstructured":"Choi HJ, Han JS. Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells. Biochim Biophys Acta. 2012;1823:1082\u201391.","journal-title":"Biochim Biophys Acta"},{"key":"1454_CR50","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1074\/jbc.M310589200","volume":"279","author":"RL Bigelow","year":"2004","unstructured":"Bigelow RL, Chari NS, Unden AB, Spurgers KB, Lee S, Roop DR, et al. Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem. 2004;279:1197\u2013205.","journal-title":"J Biol Chem"},{"key":"1454_CR51","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M800109200","volume":"283","author":"LY Bourguignon","year":"2008","unstructured":"Bourguignon LY, Peyrollier K, Xia W, Gilad E. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem. 2008;283:17635\u201351.","journal-title":"J Biol Chem"},{"key":"1454_CR52","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/emboj.2010.137","volume":"29","author":"M Zbinden","year":"2010","unstructured":"Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I. Ruiz i Altaba A. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 2010;29:2659\u201374.","journal-title":"EMBO J"},{"key":"1454_CR53","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","volume":"21","author":"G Niu","year":"2002","unstructured":"Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002;21:2000\u20138.","journal-title":"Oncogene"},{"key":"1454_CR54","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1073\/pnas.1017945108","volume":"108","author":"W Chen","year":"2011","unstructured":"Chen W, Tang T, Eastham-Anderson J, Dunlap D, Alicke B, Nannini M, et al. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci USA. 2011;108:9589\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1454_CR55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fonc.2016.00142","volume":"6","author":"M Tavallai","year":"2016","unstructured":"Tavallai M, Booth L, Roberts JL, Poklepovic A, Dent P. Rationally repurposing ruxolitinib (Jakafi ((R))) as a solid tumor therapeutic. Front Oncol. 2016;6:142.","journal-title":"Front Oncol"},{"key":"1454_CR56","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","volume":"8","author":"EH Epstein","year":"2008","unstructured":"Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8:743\u201354.","journal-title":"Nat Rev Cancer"},{"key":"1454_CR57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","volume":"27","author":"SX Atwood","year":"2015","unstructured":"Atwood SX, Sarin KY, Whitson RJ, Li JR, Kim G, Rezaee M, et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell. 2015;27:342\u201353.","journal-title":"Cancer Cell"},{"key":"1454_CR58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semcdb.2014.05.007","volume":"33","author":"R Teperino","year":"2014","unstructured":"Teperino R, Aberger F, Esterbauer H, Riobo N, Pospisilik JA. Canonical and non-canonical Hedgehog signalling and the control of metabolism. Semin Cell Dev Biol. 2014;33:81\u201392.","journal-title":"Semin Cell Dev Biol"},{"key":"1454_CR59","first-page":"2369","volume":"57","author":"J Xie","year":"1997","unstructured":"Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, et al. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res. 1997;57:2369\u201372.","journal-title":"Cancer Res"},{"key":"1454_CR60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/gcc.21935","volume":"51","author":"X Jiao","year":"2012","unstructured":"Jiao X, Wood LD, Lindman M, Jones S, Buckhaults P, Polyak K, et al. Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers. Genes Chromosomes Cancer. 2012;51:480\u20139.","journal-title":"Genes Chromosomes Cancer"},{"key":"1454_CR61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10637-018-0614-9","volume":"37","author":"M Ruiz-Borrego","year":"2019","unstructured":"Ruiz-Borrego M, Jimenez B, Antolin S, Garcia-Saenz JA, Corral J, Jerez Y, et al. A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM\/2012-12 (EDALINE) study. Investig New Drugs. 2019;37:98\u2013108.","journal-title":"Investig New Drugs"},{"key":"1454_CR62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/07357907.2013.820317","volume":"31","author":"AH Zaidi","year":"2013","unstructured":"Zaidi AH, Komatsu Y, Kelly LA, Malhotra U, Rotoloni C, Kosovec JE, et al. Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells. Cancer Investig. 2013;31:480\u20139.","journal-title":"Cancer Investig"},{"key":"1454_CR63","doi-asserted-by":"crossref","unstructured":"Rimkus TK, Carpenter RL, Qasem S, Chan M, Lo HW. Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Cancers. 2016;8. https:\/\/www.mdpi.com\/about\/announcements\/784.","DOI":"10.3390\/cancers8020022"},{"key":"1454_CR64","volume":"8","author":"RL Carpenter","year":"2013","unstructured":"Carpenter RL, Han W, Paw I, Lo HW. HER2 phosphorylates and destabilizes pro-apoptotic PUMA, leading to antagonized apoptosis in cancer cells. PLoS ONE. 2013;8:e78836.","journal-title":"PLoS ONE"},{"key":"1454_CR65","unstructured":"Carpenter RL, Lo HW. Regulation oF apoptosis by HER2 in breast cancer. J Carcinog Mutagen. 2013;2013."},{"key":"1454_CR66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20121627","volume":"451","author":"C Hindley","year":"2013","unstructured":"Hindley C, Philpott A. The cell cycle and pluripotency. Biochem J. 2013;451:135\u201343.","journal-title":"Biochem J"},{"key":"1454_CR67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.189.1.63","volume":"189","author":"N Kiuchi","year":"1999","unstructured":"Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med. 1999;189:63\u201373.","journal-title":"J Exp Med"},{"key":"1454_CR68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/scd.2007.0098","volume":"17","author":"KM Foshay","year":"2008","unstructured":"Foshay KM, Gallicano GI. Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate. Stem Cells Dev. 2008;17:269\u201378.","journal-title":"Stem Cells Dev"},{"key":"1454_CR69","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.bbamcr.2011.05.013","volume":"1813","author":"F Okumura","year":"2011","unstructured":"Okumura F, Okumura AJ, Matsumoto M, Nakayama KI, Hatakeyama S. TRIM8 regulates Nanog via Hsp90beta-mediated nuclear translocation of STAT3 in embryonic stem cells. Biochim Biophys Acta. 2011;1813:1784\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"1454_CR70","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI44745","volume":"121","author":"LL Marotta","year":"2011","unstructured":"Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, et al. The JAK2\/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors. J Clin Investig. 2011;121:2723\u201335.","journal-title":"J Clin Investig"},{"key":"1454_CR71","doi-asserted-by":"crossref","unstructured":"Snigdha K, Gangwani KS, Lapalikar GV, Singh A, Kango-Singh M. Hippo signaling in cancer: lessons from Drosophila models. Front Cell Dev Biol. 2019;7.","DOI":"10.3389\/fcell.2019.00085"},{"key":"1454_CR72","volume":"7","author":"T-H Hsu","year":"2017","unstructured":"Hsu T-H, Yang C-Y, Yeh T-H, Huang Y-C, Wang T-W, Yu J-Y. The Hippo pathway acts downstream of the Hedgehog signaling to regulate follicle stem cell maintenance in the Drosophila ovary. Sci Rep. 2017;7:4480.","journal-title":"Sci Rep"},{"key":"1454_CR73","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1101\/gad.1824509","volume":"23","author":"A Fernandez-L","year":"2009","unstructured":"Fernandez-L A, Northcott PA, Dalton J, Fraga C, Ellison D, Angers S, et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 2009;23:2729\u201341.","journal-title":"Genes Dev"},{"key":"1454_CR74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/abbs\/gmu110","volume":"47","author":"C Zhu","year":"2014","unstructured":"Zhu C, Li L, Zhao B. The regulation and function of YAP transcription co-activator. Acta Biochim Biophys Sin. 2014;47:16\u201328.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1454_CR75","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tcb.2012.04.006","volume":"22","author":"A Ramos","year":"2012","unstructured":"Ramos A, Camargo FD. The Hippo signaling pathway and stem cell biology. Trends Cell Biol. 2012;22:339\u201346.","journal-title":"Trends Cell Biol"},{"key":"1454_CR76","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.gastro.2016.05.006","volume":"151","author":"R Gruber","year":"2016","unstructured":"Gruber R, Panayiotou R, Nye E, Spencer-Dene B, Stamp G, Behrens A. YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK-STAT3 signaling. Gastroenterology. 2016;151:526\u201339.","journal-title":"Gastroenterology"},{"key":"1454_CR77","doi-asserted-by":"crossref","first-page":"12405","DOI":"10.1073\/pnas.0605579103","volume":"103","author":"M Overholtzer","year":"2006","unstructured":"Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA. 2006;103:12405\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1454_CR78","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009;459:1005\u20139.","journal-title":"Nature"},{"key":"1454_CR79","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cord\u00f3n-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537\u201349.","journal-title":"Cancer Cell"},{"key":"1454_CR80","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.2309","volume":"17","author":"S Zhang","year":"2011","unstructured":"Zhang S, Huang WC, Li P, Guo H, Poh SB, Brady SW, et al. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat Med. 2011;17:461\u20139.","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1038\/s41388-024-03046-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01454-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T13:27:12Z","timestamp":1714742832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01454-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":80,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2020,10,15]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-01454-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41388-024-03046-9","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}